NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 103 filers reported holding NURIX THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $239,595 | -32.5% | 30,483 | -14.3% | 0.00% | -100.0% |
| Q2 2023 | $355,204 | +9.1% | 35,556 | -3.1% | 0.00% | 0.0% |
| Q1 2023 | $325,682 | +23.1% | 36,676 | +52.3% | 0.00% | 0.0% |
| Q4 2022 | $264,496 | +2304.5% | 24,089 | +2640.5% | 0.00% | – |
| Q3 2022 | $11,000 | -92.8% | 879 | -84.7% | 0.00% | – |
| Q2 2021 | $152,000 | -14.6% | 5,749 | 0.0% | 0.00% | – |
| Q1 2021 | $178,000 | – | 5,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 4,508,333 | $140,164,000 | 17.73% |
| Ponoi II Management, LLC | 686,274 | $21,336,000 | 16.34% |
| Column Group LLC | 5,383,333 | $167,368,000 | 16.04% |
| Ponoi Management, LLC | 686,274 | $21,336,000 | 12.55% |
| Foresite Capital Management IV, LLC | 1,238,456 | $38,504,000 | 4.61% |
| Foresite Capital Management V, LLC | 451,522 | $14,038,000 | 4.13% |
| WestHill Financial Advisors, Inc. | 283,333 | $8,809,000 | 3.13% |
| EcoR1 Capital, LLC | 2,019,019 | $62,771,000 | 2.78% |
| Bain Capital Life Sciences Investors, LLC | 1,284,314 | $39,929,000 | 2.26% |
| DAFNA Capital Management LLC | 306,320 | $9,523,000 | 2.26% |